JP2015131797A5 - - Google Patents

Download PDF

Info

Publication number
JP2015131797A5
JP2015131797A5 JP2014231340A JP2014231340A JP2015131797A5 JP 2015131797 A5 JP2015131797 A5 JP 2015131797A5 JP 2014231340 A JP2014231340 A JP 2014231340A JP 2014231340 A JP2014231340 A JP 2014231340A JP 2015131797 A5 JP2015131797 A5 JP 2015131797A5
Authority
JP
Japan
Prior art keywords
external preparation
production promoter
versican
golden silk
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014231340A
Other languages
Japanese (ja)
Other versions
JP2015131797A (en
JP6456109B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2014231340A priority Critical patent/JP6456109B2/en
Priority claimed from JP2014231340A external-priority patent/JP6456109B2/en
Publication of JP2015131797A publication Critical patent/JP2015131797A/en
Publication of JP2015131797A5 publication Critical patent/JP2015131797A5/ja
Application granted granted Critical
Publication of JP6456109B2 publication Critical patent/JP6456109B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

<バーシカン産生促進評価>
正常ヒト繊維芽細胞5000 cells/wellに上記各抽出液を蒸発残分として1質量%の濃度となるように添加して、37℃、5%CO条件下で48時間培養した。培養後、mRNAを回収して、RT−PCRでバーシカンのmRNA発現量を測定した。なお、発現量は、内部標準物質を基準に算出した。また、対照として、抽出液の代わりに50%エタノールを添加した対照(コントロール)、及び陽性対照として抗老化作用を有するTGF−βを2ng添加した場合について、同様にmRNA発現量を測定した。結果を図1及び図2に示す。
<Versican production promotion evaluation>
It was added to normal human lines fibroblast 5000 cells / well in each extract to be 1 wt% concentration as evaporation residue, 37 ° C., for 48 hours at 5% CO 2 conditions. After culturing, mRNA was collected and the expression level of versican mRNA was measured by RT-PCR. The expression level was calculated based on the internal standard substance. In addition, as a control, mRNA expression level was measured in the same manner when a control (control) in which 50% ethanol was added instead of the extract and 2 ng of TGF-β having anti-aging action was added as a positive control. The results are shown in FIGS.

Claims (4)

ゴールデンシルクを60℃以上の酸性アルコール溶媒又はアルコールと水との酸性混合溶媒で抽出するステップ、を含むゴールデンシルク抽出物の製造方法。 Extracting the golden silk with an acidic alcohol solvent of 60 ° C. or higher or an acidic mixed solvent of alcohol and water . 請求項1に記載の製造方法により製造されるゴールデンシルク抽出物からなる、バーシカン産生促進剤。 The versican production promoter which consists of a golden silk extract manufactured by the manufacturing method of Claim 1 . 請求項に記載のバーシカン産生促進剤を含有する、皮膚外用剤。 A skin external preparation containing the versican production promoter according to claim 2 . 抗老化化粧料である請求項に記載の皮膚外用剤。 The external preparation for skin according to claim 3 , which is an anti-aging cosmetic.
JP2014231340A 2013-12-13 2014-11-14 Versican production promoter and method for producing golden silk extract Active JP6456109B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014231340A JP6456109B2 (en) 2013-12-13 2014-11-14 Versican production promoter and method for producing golden silk extract

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013257753 2013-12-13
JP2013257753 2013-12-13
JP2014231340A JP6456109B2 (en) 2013-12-13 2014-11-14 Versican production promoter and method for producing golden silk extract

Publications (3)

Publication Number Publication Date
JP2015131797A JP2015131797A (en) 2015-07-23
JP2015131797A5 true JP2015131797A5 (en) 2017-09-28
JP6456109B2 JP6456109B2 (en) 2019-01-23

Family

ID=53899343

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014231340A Active JP6456109B2 (en) 2013-12-13 2014-11-14 Versican production promoter and method for producing golden silk extract

Country Status (1)

Country Link
JP (1) JP6456109B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6544987B2 (en) * 2015-04-30 2019-07-17 ポーラ化成工業株式会社 Method of promoting elongation of fibroblasts
JP6611308B2 (en) * 2015-04-30 2019-11-27 ポーラ化成工業株式会社 Skin preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000086441A (en) * 1998-07-17 2000-03-28 Kanebo Ltd Sheet-like pack cosmetic
JP4906509B2 (en) * 2004-09-22 2012-03-28 峰川 すみ子 Modified silk and its aqueous extract
KR20130108805A (en) * 2012-03-26 2013-10-07 (주)더페이스샵 Cosmetic composition comprising golden silkworm(bombyx moril) derived materials as active ingredient

Similar Documents

Publication Publication Date Title
WO2017042607A3 (en) Compositions comprising meloxicam-cyclodextrin inclusion complexes and methods of treating acute pain
UA113181C2 (en) PROTECTION OF PROTEIN FROM OIL-CONTAINING SEEDS
JP2012140442A5 (en)
IT1393045B1 (en) COMPOSITIONS CONTAINING MONOGLICERIDES OF ORGANIC ACIDS FROM C1 TO C7 AND GLYCEROL, THEIR PREPARATION AND USE AS ANTIBACTERIALS IN THE ZOOTECHNY.
EP3242964A4 (en) Electrochemical and photoelectrochemical oxidation of 5-hydroxymethylfurfural to 2,5-furandicarboxylic acid and 2,5-diformylfuran
WO2013027984A3 (en) Cosmetic composition containing green tea component
WO2011083110A3 (en) Use of at least one extract of flowers of camellia japonica alba plena for moisturizing the skin
EA201491866A1 (en) METHOD OF HAIR TREATMENT
WO2010145008A8 (en) Use of skin care compositions comprising laminariacea extract for treatment of skin aging signs
WO2013090228A3 (en) Maesa japonica extracts and methods of use
JP2014101365A5 (en)
EA201792143A1 (en) MEDICAL FORM FOR LONG-TERM EXTRACTING OF EXISTING SUBSTANCES
BR112013014575A2 (en) in vitro or ex vivo use, cosmetic use, process, cosmetic process, isolated peptide, in vitro or ex vivo multicellular skin composition and model
JP2015131797A5 (en)
WO2014037903A3 (en) Cosmetic compositions comprising eicosapentaeninic free acid and gamma-linopenic free acid and methods of making and using same
FR3032879B1 (en) OBTAINING EXTRACT OF GAMETOPHYTES FROM BROWN ALGAE AND USE THEREOF AS ACTIVE ANTI-AGING COSMETIC PRINCIPLE
MY190399A (en) A composition comprising cistanche and ginkgo extracts, the composition useful for improving memory of a subject
EA201690216A1 (en) PHARMACEUTICAL COMPOSITIONS OF RANOLAZINE AND DRONEDARON
GB201008401D0 (en) Novel process
JP2010037221A5 (en)
WO2015023631A3 (en) Fatty acid analogs and their use
WO2017216274A3 (en) Extract of undifferentiated cells of mimosa pudica and uses thereof in dermo-cosmetics
FI20136135A (en) Method for the preparation of the resinous fatty acid soap, the fatty acid soap composition and its use
EA201690720A1 (en) METHODS AND COMPOSITIONS FOR REDUCING THE SLIPPING OF IRON OXIDE TABLETS USED IN DIRECT RECOVERY METHODS
RU2015155297A (en) METHOD FOR PRODUCING FODDER ADDITIVE BASED ON WOOD GREEN